| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00441408 |
| P698 | PubMed publication ID | 3215198 |
| P2093 | author name string | M B Ranke | |
| H Enders | |||
| J R Bierich | |||
| P Heidemann | |||
| A A Schmaltz | |||
| C Knupfer | |||
| P2860 | cites work | KARYOTYPE-PHENOTYPE CORRELATIONS IN GONADAL DYSGENESIS AND THEIR BEARING ON THE PATHOGENESIS OF MALFORMATIONS | Q33585184 |
| Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease | Q34208787 | ||
| Brief historical note: The concept of “gonadal dysgenesis” | Q34694769 | ||
| The Ullrich-Noonan syndrome (Turner phenotype). | Q34700172 | ||
| Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I | Q36061118 | ||
| Noonan syndrome: a review | Q39826480 | ||
| The Noonan syndrome--a review of the clinical and genetic features of 27 cases | Q39873401 | ||
| Turner syndrome: spontaneous growth in 150 cases and review of the literature | Q40234962 | ||
| Noonan's syndrome. IQ and specific disabilities | Q41718581 | ||
| Growth curves for height in Noonan syndrome | Q47205363 | ||
| Noonan syndrome: the changing phenotype | Q49195666 | ||
| A comprehensive scoring system for evaluating Noonan syndrome. | Q52102675 | ||
| Cardiovascular anomalies in Noonan's syndrome | Q67562556 | ||
| Possible etiologic mechanisms of the short stature in the Noonan syndrome | Q67830146 | ||
| Noonan syndrome | Q68929823 | ||
| Classic pages in obstetrics and gynecology by Henry H. Turner. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology, vol. 23, pp. 566-574, 1938 | Q69184799 | ||
| Short stature and dysmorphism in the child and adolescent female. Diagnostic dilemmas | Q71033370 | ||
| Unifying link between Noonan's and Leopard syndromes? | Q71807402 | ||
| Direct Familial Transmission of the Turner Phenotype | Q72149951 | ||
| Turner syndrome and Noonan's syndrome | Q72383556 | ||
| P433 | issue | 3 | |
| P921 | main subject | Noonan syndrome | Q1543446 |
| P304 | page(s) | 220-227 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Noonan syndrome: growth and clinical manifestations in 144 cases | |
| P478 | volume | 148 |
| Q79158985 | Adult height in Noonan syndrome |
| Q35701198 | Aneurysmal sub-arachnoid haemorrhage in patients with Noonan syndrome: a report of two cases and review of neurovascular presentations in this syndrome. |
| Q57632741 | Bases Genéticas dos Distúrbios de Crescimento |
| Q35597673 | Clinical manifestations of Noonan syndrome |
| Q42749590 | Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype? |
| Q48444899 | Cognitive functioning of adults with Noonan syndrome: a case-control study |
| Q90254897 | Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome |
| Q91995250 | Correlation between genetic heterogeneity and variability for response to growth hormone in Noonan syndrome |
| Q73694785 | Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome |
| Q48309238 | Development of disease-specific growth charts in Turner syndrome and Noonan syndrome |
| Q36337354 | Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry |
| Q36127065 | Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency |
| Q56976814 | GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome) |
| Q33674364 | Genital tract function in men with Noonan syndrome |
| Q71499766 | Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood |
| Q60923377 | Growth hormone therapy in patients with Noonan syndrome |
| Q71072193 | Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience |
| Q35261008 | Growth monitoring: testing the new guidelines |
| Q40229273 | Growth references for Japanese individuals with Noonan syndrome. |
| Q54491263 | Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway. |
| Q41438463 | Growth, short stature, and the use of growth hormone: considerations for the practicing pediatrician--an update |
| Q70791238 | Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society |
| Q67865578 | Hypertrophic obstructive cardiomyopathy as a manifestation of a cardiocutaneous syndrome (Noonan syndrome) |
| Q34015929 | Impaired Sertoli cell function in males diagnosed with Noonan syndrome |
| Q57199506 | Le syndrome de noonan: une énigme |
| Q37793648 | Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines |
| Q59215649 | Noonan syndrome |
| Q36034737 | Noonan syndrome and Turner syndrome patients respond similarly to 4 years' growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program |
| Q35846971 | Noonan syndrome and related disorders: alterations in growth and puberty |
| Q71141716 | Noonan syndrome with double-chambered right ventricle |
| Q35837138 | Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. |
| Q33806161 | Noonan syndrome: clinical aspects and molecular pathogenesis |
| Q46363162 | Noonan syndrome: from phenotype to growth hormone therapy |
| Q58811289 | Noonan's Syndrome: Abnormalities of the Growth Hormone/IGF-I Axis and the Response to Treatment with Human Biosynthetic Growth Hormone |
| Q44153668 | PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13. |
| Q53400960 | Response to long-term growth hormone therapy in patients affected by RASopathies and growth hormone deficiency: Patterns of growth, puberty and final height data. |
| Q35269789 | Short stature in Noonan syndrome: response to growth hormone therapy. |
| Q44360479 | Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome |
| Q34567819 | The natural history of Noonan syndrome: a long-term follow-up study |
| Q51984213 | [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation]. |
| Q37898795 | rhGH safety and efficacy update |
Search more.